Skip to content
The Policy VaultThe Policy Vault

Cabometyx (cabozantinib) — Highmark

pancreatic neuroendocrine tumors (pNET)

Initial criteria

  • age ≥ 12 years
  • diagnosis of unresectable, locally advanced or metastatic, well-differentiated pNET (ICD-10: C25.4)
  • previously treated for pNET